147 related articles for article (PubMed ID: 21710244)
1. Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin.
Afzal S; Jensen SA; Sørensen JB; Henriksen T; Weimann A; Poulsen HE
Cancer Chemother Pharmacol; 2012 Feb; 69(2):301-7. PubMed ID: 21710244
[TBL] [Abstract][Full Text] [Related]
2. Reference ranges of urinary biomarkers of oxidized guanine in (2'-deoxy)ribonucleotides and nucleic acids.
Andreoli R; Mutti A; Goldoni M; Manini P; Apostoli P; De Palma G
Free Radic Biol Med; 2011 Jan; 50(2):254-61. PubMed ID: 21075202
[TBL] [Abstract][Full Text] [Related]
3. Urinary analysis of 8-oxoguanine, 8-oxoguanosine, fapy-guanine and 8-oxo-2'-deoxyguanosine by high-performance liquid chromatography-electrospray tandem mass spectrometry as a measure of oxidative stress.
Malayappan B; Garrett TJ; Segal M; Leeuwenburgh C
J Chromatogr A; 2007 Oct; 1167(1):54-62. PubMed ID: 17765254
[TBL] [Abstract][Full Text] [Related]
4. The effect of smoking on the urinary excretion of 8-oxodG and 8-oxoGuo in patients with type 2 diabetes.
Sørensen AS; Kjær LK; Petersen KM; Henriksen T; Cejvanovic V; Pedersen O; Hansen T; Christensen CK; Brandslund I; Poulsen HE
Scand J Clin Lab Invest; 2017 Jul; 77(4):253-258. PubMed ID: 28287274
[TBL] [Abstract][Full Text] [Related]
5. Short-term moderate exercise programs reduce oxidative DNA damage as determined by high-performance liquid chromatography-electrospray ionization-mass spectrometry in patients with colorectal carcinoma following primary treatment.
Allgayer H; Owen RW; Nair J; Spiegelhalder B; Streit J; Reichel C; Bartsch H
Scand J Gastroenterol; 2008 Aug; 43(8):971-8. PubMed ID: 18609189
[TBL] [Abstract][Full Text] [Related]
6. Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes.
Broedbaek K; Siersma V; Henriksen T; Weimann A; Petersen M; Andersen JT; Jimenez-Solem E; Hansen LJ; Henriksen JE; Bonnema SJ; de Fine Olivarius N; Friis S; Poulsen HE
Redox Biol; 2015; 4():34-9. PubMed ID: 25498965
[TBL] [Abstract][Full Text] [Related]
7. Diurnal variation of urinary markers of nucleic acid oxidation.
Grew IS; Cejvanovic V; Broedbaek K; Henriksen T; Petersen M; Andersen JT; Jimenez-Solem E; Weimann A; Poulsen HE
Scand J Clin Lab Invest; 2014 Jun; 74(4):336-43. PubMed ID: 24628455
[TBL] [Abstract][Full Text] [Related]
8. Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2'-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry.
Henriksen T; Hillestrøm PR; Poulsen HE; Weimann A
Free Radic Biol Med; 2009 Sep; 47(5):629-35. PubMed ID: 19501155
[TBL] [Abstract][Full Text] [Related]
9. Gender-related reference intervals of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine determined by liquid chromatography-tandem mass spectrometry in Serbian population.
Topic A; Francuski D; Markovic B; Stankovic M; Dobrivojevic S; Drca S; Radojkovic D
Clin Biochem; 2013 Mar; 46(4-5):321-6. PubMed ID: 23261837
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer.
Loft S; Svoboda P; Kasai H; Tjønneland A; Vogel U; Møller P; Overvad K; Raaschou-Nielsen O
Carcinogenesis; 2006 Jun; 27(6):1245-50. PubMed ID: 16364924
[TBL] [Abstract][Full Text] [Related]
11. Classification and Temporal Variability in Urinary 8-oxodG and 8-oxoGuo: Analysis by UHPLC-MS/MS.
Li Z; Yao Y; Zhang Y; Zhang Y; Shao Y; Tang C; Qu W; Zhou Y
Sci Rep; 2019 Jun; 9(1):8187. PubMed ID: 31160621
[TBL] [Abstract][Full Text] [Related]
12. Oxidatively generated DNA/RNA damage in psychological stress states.
Jørgensen A
Dan Med J; 2013 Jul; 60(7):B4685. PubMed ID: 23809980
[TBL] [Abstract][Full Text] [Related]
13. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
Tournigand C; Cervantes A; Figer A; Lledo G; Flesch M; Buyse M; Mineur L; Carola E; Etienne PL; Rivera F; Chirivella I; Perez-Staub N; Louvet C; André T; Tabah-Fisch I; de Gramont A
J Clin Oncol; 2006 Jan; 24(3):394-400. PubMed ID: 16421419
[TBL] [Abstract][Full Text] [Related]
14. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.
Giacchetti S; Bjarnason G; Garufi C; Genet D; Iacobelli S; Tampellini M; Smaaland R; Focan C; Coudert B; Humblet Y; Canon JL; Adenis A; Lo Re G; Carvalho C; Schueller J; Anciaux N; Lentz MA; Baron B; Gorlia T; Lévi F;
J Clin Oncol; 2006 Aug; 24(22):3562-9. PubMed ID: 16877722
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F
J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.
Larsen EL; Cejvanovic V; Kjaer LK; Pedersen MT; Popik SD; Hansen LK; Andersen JT; Jimenez-Solem E; Broedbaek K; Petersen M; Weimann A; Henriksen T; Lykkesfeldt J; Torp-Pedersen C; Poulsen HE
Br J Clin Pharmacol; 2017 Aug; 83(8):1643-1653. PubMed ID: 28185274
[TBL] [Abstract][Full Text] [Related]
17. Evidence for attenuated cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine removal in cancer patients.
Cooke MS; Rozalski R; Dove R; Gackowski D; Siomek A; Evans MD; Olinski R
Biol Chem; 2006 Apr; 387(4):393-400. PubMed ID: 16606337
[TBL] [Abstract][Full Text] [Related]
18. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of oxidative stress to nucleic acids: background levels and effects of body mass index and life-style factors in an urban paediatric population.
Protano C; Andreoli R; Mutti A; Petti S; Vitali M
Sci Total Environ; 2014 Dec; 500-501():44-51. PubMed ID: 25217743
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
